EFFICACY OF RECOMBINANT THROMBOMODULIN AND ANTITHROMBIN COMBINATION THERAPY IN SEPSIS-INDUCED DIC

被引:0
|
作者
Takahashi, Hiroyuki
Kuriyama, Keiichi
Yoshikawa, Kazuhide
Ueki, Yuzuru
Takahashi, Masateru
Isotani, Eiji
机构
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
1019
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
    Toshiaki Iba
    Akiyoshi Hagiwara
    Daizoh Saitoh
    Hideaki Anan
    Yutaka Ueki
    Koichi Sato
    Satoshi Gando
    Annals of Intensive Care, 7
  • [22] The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC
    Takumi Aota
    Hideo Wada
    Yoshiki Yamashita
    Takeshi Matsumoto
    Kohshi Ohishi
    Kei Suzuki
    Hiroshi Imai
    Masanobu Usui
    Shuji Isaji
    Naoyuki Katayama
    International Journal of Hematology, 2016, 103 : 173 - 179
  • [23] The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC
    Aota, Takumi
    Wada, Hideo
    Yamashita, Yoshiki
    Matsumoto, Takeshi
    Ohishi, Kohshi
    Suzuki, Kei
    Imai, Hiroshi
    Usui, Masanobu
    Isaji, Shuji
    Katayama, Naoyuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (02) : 173 - 179
  • [24] Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation-A meta-analysis
    Kato, Hideo
    Hagihara, Mao
    Asai, Nobuhiro
    Umemura, Takumi
    Hirai, Jun
    Mori, Nobuaki
    Yamagishi, Yuka
    Iwamoto, Takuya
    Mikamo, Hiroshige
    THROMBOSIS RESEARCH, 2023, 226 : 165 - 172
  • [25] Recombinant Thrombomodulin Attenuates Sepsis-Induced Pulmonary Injury Via Protection of Endothelial Glycocalyx Structure
    Yano, H.
    Okada, H.
    Takemura, G.
    Suzuki, K.
    Takada, C.
    Zaikokuji, R.
    Muraki, I.
    Kakino, Y.
    Okamoto, H.
    Doi, T.
    Yoshida, S.
    Ushikoshi, H.
    Ogura, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [26] EVALUATION OF PROTOCOL BASED ADMINISTRATION OF RECOMBINANT THROMBOMODULIN IN PATIENTS WITH SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION
    Kato, Takayuki
    Murao, Atsushi
    Imashuku, Yasuhiko
    Fujino, Kazunori
    Yamane, Tetsunobu
    Tabata, Takahisa
    Tsujita, Yasuyuki
    Matsushita, Mikiko
    Takahashi, Kan
    Matumura, Kazuhiro
    Eguchi, Yutaka
    SHOCK, 2017, 47 (06): : 111 - 111
  • [27] Recombinant Thrombomodulin Attenuates Sepsis-Induced Myocardial Dysfunction via Protection of Endothelial Glycocalyx Structure
    Yamaji, Fuminori
    Okada, Hideshi
    Takemura, Genzou
    Suzuki, Kodai
    Takada, Chihiro
    Miyazaki, Nagisa
    Ogura, Shinji
    CIRCULATION, 2017, 136
  • [28] Should we treat sepsis-induced DIC with anticoagulants?
    Yu Inata
    Journal of Intensive Care, 8
  • [29] Should we treat sepsis-induced DIC with anticoagulants?
    Inata, Yu
    JOURNAL OF INTENSIVE CARE, 2020, 8 (01)
  • [30] RECOMBINANT THROMBOMODULIN (RTM) MAY BE EFFECTIVE FOR SEPSIS WITH DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
    Namba, Yoshitomo
    Sasaki, Jun
    Hayashi, Makoto
    Watanabe, Kazumasa
    Hayashi, Munetaka
    Narihara, Kentarou
    CRITICAL CARE MEDICINE, 2010, 38 (12) : U121 - U121